Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TARGET: Aliskiren, HCTZ, and Moxonidine in Obesity-Related Hypertension
NCT01138423Phase 4Completed
- Start
- Aug 2010
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aliskiren in hypertension (HTN). Started Aug 2010; status: completed.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01138423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01138423.